Navigation Links
Verathon Inc., maker of GlideScope(R) Video Laryngoscopes, Introduces Free Grant Writing Kit for EMS Professionals
Date:2/1/2008

Mueller, VP of Marketing, Verathon Medical, 425.867.1348, Ext. 5600. Alternate Contacts: Nansea Carmichael, Executive Assistant - Marketing, 425.867.1348 Ext. 5607; Jessica McNerney, Executive Assistant to Gerald McMorrow, Verathon Inc., 425.867.1348, Ext. 5554.

Copyright (C) 2008, Verathon Inc. BladderScan(R), GlideScope(R), GVL(R), Verathon(R), and Verathon Medical(R) are either registered trademarks or trademarks of Verathon Inc. in the United States and/or other countries. All rights reserved.

(i) Wang H, Yealy D, Annals of Emergency Medicine. 2006;47(6):532-541.

(ii) Wang HE, Peitzman AB, Cassidy LD, Adelson PD, Yealy DM, Out-of

hospital endotracheal intubation and outcome after traumatic brain

injury, Annals of Emergency Medicine, November 2004, Vol. 44, Issue

5, Pages 439-450.)


'/>"/>
SOURCE Verathon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
2. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2007 Washington State Technology Fast 50 for 4th Time in Past 6 Years
3. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
4. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
5. Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic
6. Herman Miller, Inc., Announces Strategic Acquisition of Brandrud Furniture, Inc. to Expand Its Product Offerings and Competitive Position in the Healthcare Furnishings Sector
7. New Data From Shared Health, Inc., Proves Effectiveness of Health Information Exchange for Improving Patient Outcomes at the Point of Care
8. gloStream, Inc., Announces Formation of Nationwide Certified Partner Network
9. Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
10. Tela Sourcing, Inc., an Adaptis Company, Acquires HealthASPex Business
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ow cost, non-invasive alternative to conventional ...ted of having coronary artery disease; true even i...ues, according to a study performed at the Thomas ..., The study included 31 patients who had one or m...scovered during coronary CTA. Calcified plaques in...
(Date:12/1/2008)...chers used a new imaging technique to take high qu...ocular inflammation in mice, and the technology co...es of the eye that may cause blindness. , The st...oimmune Uveoretinitis Using Topical Endoscopic Fun...e Correlation," was published in the Association f...
(Date:12/1/2008)...the first time how microscopic crystals form sound... at the ends of cilia tiny cellular hairs in the ... play an important role in detecting sound, mainta...odged ear crystals are to blame for the most commo...tional vertigo, the disorder plagues up to 10 perc...
(Date:12/1/2008)...RNewswire-FirstCall/ -- Mach One Corporation,(Pin...at develops products,that produce a positive long...rket, announced today that Mr. Tad Ballantyne will...upon the closing of the acquisition of Pacific Rim...ntyne is an officer and/or director of a number of...
Breaking Medicine News(10 mins):Health News:New technique captures high-res images of full retina 2Health News:Can you hear me now? How the inner ear's sensors are made 2Health News:Mr. Tad Ballantyne to Join Mach One Board of Directors 2
...to assess the risk of heart disease in British bla...gly assessed. // ETHRISK is for everyday use in t...s. It has been developed by researchers at the Uni... of the heart disease risks of seven British black...
...son whether to be self-employed or not lies in the...nvironment comparatively have lesser effect than g...s of twins shows. It was also proved to be true up... Hospital, London, Imperial College, London, and C...
...ial year is to be announced by the health minister.../feel that they would try to convince that what se...y only related to a small number of NHS organisati...ced during the current financial year. But they w...
...first suspected to be a problem with immune system...from a new infection//. Later, it was detected a...lated all over the world and more than 22 million ...pposed to be living with it – 25 years ago it was ...
Other Medicine News:Health News:New Web- Based Calculator to Assess Heart Disease Risk 2Health News:UK Government Plans On Tackling Health Service Deficits 2
(Date:11/24/2008)...RNewswire-FirstCall/ -- Leaders of Schering-Plough...te for investors on the company,s research pipelin...at includes 46 new entities in clinical trials or ...ies. , , "Research and development is addin...ntinue our transformation," said Fred Hassan, chai...
(Date:11/24/2008)...ay Unveils Rich Development Pipeline of Compounds ...RTH, N.J., Nov. 24 Scher...ed top-line results of a long-term Phase III clini...(TM) (asenapine) demonstrating efficacy and safety...trial, asenapine was statistically significantly m...
(Date:11/24/2008)... GeneThera, Inc.,(Pink S...ring its Real Time,PCR test for Johne,s disease t... GeneThera is set to begin offering its Johne,s di... According to GeneThera Chairman, Dr. Tony Milici...me PCR test for Johne,s disease,called HerdGuard...
(Date:11/24/2008)..., November 24 NicOx,S.A...the third pivotal phase,3 study for naproxcinod i...tistically significant result (p<0.001) on all ... Naproxcinod 750 mg bid showed the same,gastroint...d pressure profile,to placebo. Naproxcinod is the...
Breaking Medicine Technology:Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 2Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 2Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 3Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 5AGU journal highlights Sept 3 2008 4700 1AGU journal highlights Sept 3 2008 4700 2AGU journal highlights Sept 3 2008 4700 3AGU journal highlights Sept 3 2008 4700 4AGU journal highlights Sept 3 2008 4700 5AGU journal highlights Sept 3 2008 4700 6AGU journal highlights Sept 3 2008 4700 7Demystifying Medicare and Long Term Care Insurance Healthcare Liaison Workshop 9 20 Shows Consumers How to Make Choices 26030 1Demystifying Medicare and Long Term Care Insurance Healthcare Liaison Workshop 9 20 Shows Consumers How to Make Choices 26030 2Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9 2008 7458 1Monitoring immune responses in disease 26024 1
...ERKELEY HEIGHTS, NJ – June 4, 2007 – G...sentation of results,from a Phase 2 clinical trial...rate injection), plus rituximab (Rituxan®;,Gen...lapsed or,refractory non-Hodgkin’s lymphoma ...ng of the American Society of Clinical,Oncology (A...
...HICAGO--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Th...clinical collaborators today,reported updated Phas...etween abnormal p53, tumor responses and increased... with recurrent,squamous cell carcinoma of the hea...ed today at the annual meeting of the American,Soc...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: